Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $546.14 | 33 | 97.7% |
| Consulting Fee | $12.99 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $156.72 | 7 | $0 (2018) |
| AbbVie, Inc. | $139.54 | 11 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $69.02 | 3 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.72 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.84 | 3 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $29.28 | 2 | $0 (2017) |
| Intercept Pharmaceuticals, Inc. | $28.36 | 2 | $0 (2020) |
| Prometheus Laboratories Inc. | $18.38 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $16.34 | 1 | $0 (2017) |
| PFIZER INC. | $15.13 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $15.37 | 1 | Intercept Pharmaceuticals, Inc. ($15.37) |
| 2019 | $12.99 | 1 | INTERCEPT PHARMACEUTICALS, INC. ($12.99) |
| 2018 | $156.18 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.72) |
| 2017 | $374.59 | 22 | Allergan Inc. ($130.12) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/11/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 12/13/2019 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Consulting Fee | In-kind items and services | $12.99 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 12/20/2018 | Prometheus Laboratories Inc. | — | Food and Beverage | In-kind items and services | $18.38 | General |
| 12/19/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Lower GI | ||||||
| 05/14/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/04/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/15/2018 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Endocrinology | ||||||
| 02/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Lower GI | ||||||
| 02/06/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: Lower GI | ||||||
| 01/23/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Immunology | ||||||
| 01/22/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Immunology | ||||||
| 10/12/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Immunology | ||||||
| 10/05/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 08/04/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Endocrinology | ||||||
| 08/02/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Immunology | ||||||
| 07/24/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Immunology | ||||||
| 07/14/2017 | Valeant Pharmaceuticals North America LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug), MOVIPREP, XIFAXANIBSD | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/14/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Lower GI | ||||||
| 07/10/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/07/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/14/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 214 | 217 | $212,959 | $26,753 |
| 2022 | 9 | 280 | 288 | $201,915 | $27,498 |
| 2021 | 9 | 352 | 363 | $232,423 | $33,778 |
| 2020 | 8 | 247 | 252 | $155,107 | $22,501 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 67 | 68 | $69,646 | $13,278 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 56 | $23,155 | $3,751 | 16.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $51,921 | $2,805 | 5.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 18 | 18 | $8,128 | $2,084 | 25.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $35,258 | $2,044 | 5.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $15,572 | $1,516 | 9.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $8,979 | $1,242 | 13.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 12 | 12 | $300.00 | $32.56 | 10.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 49 | 49 | $65,268 | $9,697 | 14.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 73 | 75 | $39,023 | $4,475 | 11.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $50,536 | $4,344 | 8.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $16,725 | $2,255 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 28 | $6,831 | $2,071 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $8,748 | $1,791 | 20.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 13 | 13 | $6,864 | $1,486 | 21.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 15 | $7,193 | $1,261 | 17.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 29 | 30 | $727.00 | $116.76 | 16.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 77 | 78 | $101,478 | $15,431 | 15.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 88 | 92 | $43,350 | $5,310 | 12.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 40 | 40 | $45,928 | $3,909 | 8.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $11,618 | $2,622 | 22.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 18 | 18 | $9,294 | $2,237 | 24.1% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 14 | 14 | $13,343 | $1,979 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $5,083 | $1,491 | 29.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 12 | $890.00 | $572.80 | 64.4% |
About Dr. Mark Branda, MD
Dr. Mark Branda, MD is a Gastroenterology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861619058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Branda, MD has received a total of $559.13 in payments from pharmaceutical and medical device companies, with $15.37 received in 2020. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($546.14).
As a Medicare-enrolled provider, Branda has provided services to 1,093 Medicare beneficiaries, totaling 1,120 services with total Medicare billing of $110,530. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Lewiston, ME
- Active Since 04/19/2007
- Last Updated 01/27/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1861619058
Products in Payments
- Humira (Biological) $108.31
- VIBERZI (Drug) $100.14
- Amitiza (Drug) $65.12
- LINZESS (Drug) $56.58
- UCERIS (Drug) $40.61
- XIFAXAN (Drug) $37.14
- Creon (Drug) $31.23
- XIFAXANIBSD (Drug) $30.99
- OCALIVA (Drug) $28.36
- PREPOPIK (Drug) $16.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lewiston
Dr. Oswaldo Bisbal, Md, MD
Gastroenterology — Payments: $3,688
Dr. Benjamin Stein, M.d.,, M.D.,
Gastroenterology — Payments: $3,409
Emil Miskovsky, Md, MD
Gastroenterology — Payments: $2,859
Dr. Winoah Henry, M.d, M.D
Gastroenterology — Payments: $1,659
Catherine Mccrann, Md, MD
Gastroenterology — Payments: $910.59
Lee Hixson, M.d, M.D
Gastroenterology — Payments: $314.22